Cognitive-behavioural therapy for schizophrenia: filling the therapeutic vacuum
Cognitive-behavioural therapy for schizophrenia: filling the therapeutic vacuum
D.T. has accepted hospitality from Pfizer, Lilly, Janssen and Organon. He has undertaken a consultancy for Pfizer, has sat on two advisory boards and has acted as principal investigator on a Pfizer-funded trial into the efficacy of CBT in schizophrenia in community settings. D.K. has received hospitality from Pfizer, Lilly and Janssen and has sat on an advisory board for Pfizer.
98-99
Turkington, Douglas
3e0aca69-c932-4fb6-9145-6e19c7310700
Kingdon, David
14cdc422-10b4-4b2d-88ec-24fde5f4329b
Chadwick, Paul
13a767ec-4c8d-467b-85df-ca04a8d11a8e
2003
Turkington, Douglas
3e0aca69-c932-4fb6-9145-6e19c7310700
Kingdon, David
14cdc422-10b4-4b2d-88ec-24fde5f4329b
Chadwick, Paul
13a767ec-4c8d-467b-85df-ca04a8d11a8e
Turkington, Douglas, Kingdon, David and Chadwick, Paul
(2003)
Cognitive-behavioural therapy for schizophrenia: filling the therapeutic vacuum.
British Journal of Psychiatry, 183 (2), .
Abstract
D.T. has accepted hospitality from Pfizer, Lilly, Janssen and Organon. He has undertaken a consultancy for Pfizer, has sat on two advisory boards and has acted as principal investigator on a Pfizer-funded trial into the efficacy of CBT in schizophrenia in community settings. D.K. has received hospitality from Pfizer, Lilly and Janssen and has sat on an advisory board for Pfizer.
This record has no associated files available for download.
More information
Published date: 2003
Identifiers
Local EPrints ID: 40636
URI: http://eprints.soton.ac.uk/id/eprint/40636
ISSN: 0007-1250
PURE UUID: 80b7af81-eff0-4926-8098-a53e0ce22f4d
Catalogue record
Date deposited: 07 Jul 2006
Last modified: 08 Jan 2022 06:59
Export record
Contributors
Author:
Douglas Turkington
Author:
David Kingdon
Author:
Paul Chadwick
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics